The primary aim of this study is to investigate the feasibility of the program AMOR for pregnant women and new mothers with Attention Deficit Hyperactivity Disorder (ADHD), by examining adherence, credibility, treatment satisfaction, and negative effects. The secondary objective is to obtain preliminary information about the short-term clinical outcomes of the program on self-report scales assessing symptoms of ADHD, stress, anxiety, depression, difficulties in emotion regulation, and quality of life. The main questions this study aims to answer: 1. To what extent will pregnant women and new mothers with ADHD adhere to, find useful, be satisfied with, and experience negative effects of the program AMOR? 2. To what extent will pregnant women and new mothers with ADHD experience improvements in ADHD symptoms, stress, anxiety, depression, difficulties in emotion regulation, and quality of life? Participants will: * listen to the 10 podcasts in the program * attend the 10 online guided sessions in the program * fill in questionnaires related to the primary and secondary objectives * some will be invited to participate in an online semi-structured interview
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The Negative Effects Questionnaire (NEQ)
Timeframe: From enrollment to the end of the program 11 weeks
The Credibility and Expectancy Scale (CEQ)
Timeframe: From enrollment to the end of the program 11 weeks
Adherence
Timeframe: From enrollment to the end of the program
The Client Satisfaction Questionare (CSQ-8)
Timeframe: From enrollment to the end of the program 11 weeks